McKinney Man Brings Awareness to Men s Breast Cancer – NBC 5 Dallas-Fort Worth nbcdfw.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nbcdfw.com Daily Mail and Mail on Sunday newspapers.
Whiterabbit, Creator of AI to Improve and Streamline Breast Cancer Diagnoses, Emerges from Stealth to Announce New CEO and FDA Clearance
Startup s AI technology increases breast cancer screening compliance and empowers radiologists to interpret results faster, improving patient experience and outcomes
News provided by
Share this article
Share this article
SANTA CLARA, Calif., May 11, 2021 /PRNewswire/ Whiterabbit, an AI technology company focused on early breast cancer detection, today announced the appointment of Alexander Sardiña, MD as its new CEO and the recent FDA clearance of its first medical software product, WRDensity. Whiterabbit delivers on the three factors critical to eradicating late-stage breast cancer ensuring timely screening through improved compliance, expediting result turnaround times, and providing radiologists with AI-supported tools that enhance clinical outcomes.
Photo: Radovanovic96/Getty Images
A new startup called Whiterabbit has emerged from stealth to announce its new CEO and the FDA clearance of its artificial intelligence-enabled breast cancer screening product.
The company has developed a line of products targeting the mammography space to enable early and accurate breast cancer detection, with the goal of eradicating late-stage breast cancers in the U.S. by 2025.
The WRDensity software received FDA 510(k) clearance last October. It uses AI to provide radiologists with data on the level of breast density, a risk factor of breast cancer.
Whiterabbit also has a tool that reminds patients to schedule breast cancer screening appointments, called ACT, and one that assigns patients a risk score to help providers devise a screening plan for more consistent follow-up recommendations, called WRRisk.
Breast Cancer AI Company Whiterabbit Receives FDA Clearance for WRDensity
Startup’s AI technology increases breast cancer screening compliance and empowers radiologists to interpret results faster, improving patient experience and outcomes
May 11, 2021 Whiterabbit, an AI technology company focused on early breast cancer detection, today announced the appointment of Alexander Sardiña, M.D., as its new CEO and the recent FDA clearance of its first medical software product, WRDensity. Whiterabbit delivers on the three factors critical to eradicating late-stage breast cancer ensuring timely screening through improved compliance, expediting result turnaround times, and providing radiologists with AI-supported tools that enhance clinical outcomes.